Cancer Research Landon Prizes for Basic and Translational Cancer Research  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 40, 2268-2272, July 1, 1980]
© 1980 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pallante, S. L.
Right arrow Articles by Colvin, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pallante, S. L.
Right arrow Articles by Colvin, M.

Quantitation by Gas Chromatography-Chemical Ionization-Mass Spectrometry of Phenylalanine Mustard in Plasma of Patients1

Sharon L. Pallante2, Catherine Fenselau, Robert G. Mennel, Robert B. Brundrett, Mark Appler, Neil B. Rosenshein and Michael Colvin

Department of Pharmacology and Experimental Therapeutics [S. L. P., C. F., M. A.], Department of Obstetrics and Gynecology [N. B. R.], and the Oncology Center [R. G. M., R. B. B., M. C.], The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205

An unambiguous and sensitive method based on gas chromatography-chemical ionization-mass spectrometry has been developed to quantitate L-phenylalanine mustard and has been applied to measure levels in plasma of five patients receiving 0.15 to 0.25 mg/kg (10 to 17 mg) of the drug p.o. Peak plasma levels of 50 to 190 ng/ml were found to occur between 0.7 and 2.3 hr after ingestion. The time for the plasma level to fall to one-half of the peak value varied from 0.6 to 3 hr, and very low levels (<2 ng/ml) were present by 24 hr.

1 This research was supported by USPHS NIH Grants CA-16783, CA-00103, GM-21248, and CA-00673. These data were presented in part at the 27th Annual Conference on Mass Spectrometry and Allied Topics, Seattle, Wash., June 3 to 8, 1979.

2 To whom requests for reprints should be addressed, at the Department of Pharmacology and Experimental Therapeutics, 725 North Wolfe Street, Baltimore, Md., 21205.

Received 10/15/79. Accepted 3/21/80.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1980 by the American Association for Cancer Research.